• Company Infomation
  • Product Infomation
  • Contact us
  1. TOP
  2. History

History

April 1929 A joint-stock company, "Society for Nutrition and Raising Children " was established in Daimon Shiba-koen, Tokyo . "WAKAMOTO" was released.
October 1932 Tokyo Plant was established in Kinuta-mura, Tokyo (present address:Unane-cho, Setagaya-ku, Tokyo ).
January 1933 Society for Nutrition and Raising Children Co., Ltd. was established.
July 1943 Trade name was changed to "WAKAMOTO PHARMACEUTICAL CO., LTD."
May 1949 Listed on the Tokyo Stock Exchange
November Head Office was relocated to Marunouchi Building , Marunouchi, Chiyoda-ku, Tokyo .
February 1954 Entry into cosmetics category. Launched "Zeora Toothpaste".
September 1956 Establishment of manufacturing method for coenzyme-type vitamin B2 .Launched FAD preparation, "Wakadenin Injection".
January 1962 Launched "Strong Wakamoto" with enrichment of digestive enzymes, active lactobacillus, vitamin B1 , vitamin B2 , and nicotinic-acid amide.
June 1968 Sagami Ohi Plant and a research laboratory were newly built in Ohi-cho, Kanagawa.
November Head Office was relocated to Nihonbashi, Chuo-ku, Tokyo .
June 1970 Osaka Branch was newly built in Higashi Yodogawa-ku, Osaka City .
August Launched antibiotic and chemotherapeutic drug-resistant lactobacillus preparation "Lebenin".
February 1979 Nagoya Sales Branch was newly built in Higashi-ku, Nagoya .
Nobember Sagami Research Building was established.
August 1983 Launched therapeutic dentifrice, "Coral".
September Listed on the first section of the Tokyo Stock Exchange.
October Sapporo Sales Branch was newly built in Toyohira-ku, Sapporo City .
December 1988 Fukuoka Sales Branch was newly built in Higashi-ku, Fukuoka City .
January 1989 First convertible debenture issue with property security, a total of 4 billion.
May Launched water soluble nonsteroidal anti-inflammatory ophthalmic solution, "Diclod Ophthalmic Solution".
December 1995 Launched lactobacillus preparation, "Wakamoto Intestinal Drug ".
Nobember 1999 Launched therapeutic agent for glaucoma and ocular hypertension, "RYSMON TG Ophthalmic Solution" to which a technique of thermoresponsive gel was applied, first of its kind in the world.
Nobember 2000 Launched therapeutic agent for allergic conjunctivitis, "Zepelin Ophthalmic Solution 0.1%".
August 2002 Sagami Ohi Plant acquired ISO14001 Certification.
April 2005 Launched quick kit of adenovirus antigen for ophthalmology, "Capilia Adeno Eye".
Nobember Launched therapeutic dentifrice, "Avant Bise".
July 2007 Launched therapeutic agent for glaucoma and ocular hypertension, "Nipradilol Ophthalmic Solution 0.25%".
(the first product used None-Preservative Multi-dose Container)
September 2008 Building of the second culture facility was completed.
March 2010 Building of the second ophthalmic solution facility of the Sagami Ohi Plant was completed.
October 2010 Head Office was relocated to 2-1-6, Nihonbashi Honcho, Chuo-ku,Tokyo.
May 2011 It merges a consolidated subsidiary "Shin-Ei".
October 2012 Osaka Branch was relocated to 1-8-9,nishimiyahara,Yodogawa-ku,Osaka City.
April 2014 Head Office was relocated to 2-2-2,Nihonbashi Honcho,Chuo-ku,Tokyo.
Company Information
  1. Message
  2. Profile
  3. Corporate profile video
  4. History
Profuct Information
  1. Message